Early TAVR Beneficial for Asymptomatic Severe Aortic Stenosis
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- Early transcatheter aortic valve replacement (TAVR) is better than clinical surveillance for reducing the incidence of death, stroke, and unplanned hospitalization for cardiovascular causes among patients with asymptomatic severe aortic stenosis, according to a study published online Oct. 28 in the New England Journal of Medicine. The research was published to coincide with the annual Transcatheter Cardiovascular Therapeutics conference, held from Oct. 27 to 30 in Washington, D.C.
Philippe Généreux, M.D., from Morristown Medical Center in New Jersey, and colleagues randomly assigned patients from 75 centers with asymptomatic severe aortic stenosis to undergo early TAVR with transfemoral placement of a balloon-expandable valve or clinical surveillance (455 and 446 patients, respectively).
The researchers found that 26.8 and 45.3 percent of patients in the TAVR and clinical surveillance groups had a primary end point event (composite of death, stroke, or unplanned hospitalization for cardiovascular causes; hazard ratio, 0.50). Among patients assigned to TAVR and clinical surveillance, death occurred in 8.4 and 9.2 percent, respectively; stroke in 4.2 and 6.7 percent; and unplanned hospitalization for cardiovascular causes in 20.9 and 41.7 percent. Eighty-seven percent of patients in the clinical surveillance group underwent aortic valve replacement during a median follow-up of 3.8 years.
"Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to guideline-recommended clinical surveillance in reducing the composite end point of death, stroke, or unplanned hospitalization for cardiovascular causes," the authors write.
The study was funded by Edwards Lifesciences.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
More Than One in 10 Surgical Patients Face Food Insecurity
FRIDAY, June 20, 2025 -- Food insecurity is a significant burden among U.S. surgical patients, according to a study published online June 18 in JAMA Surgery. Annabelle...
Survival Up for CABG With Surgical Ablation in Atrial Fibrillation
FRIDAY, June 13, 2025 -- Medicare beneficiaries with preexisting atrial fibrillation undergoing coronary artery bypass grafting (CABG) who undergo concomitant surgical ablation...
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
THURSDAY, June 5, 2025 -- For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.